Connor, Clark & Lunn Investment Management Ltd.
Position in SVRA — Savara Inc
CIK 1596800
VANCOUVER, A1
Position in SVRA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$670,826
+$219,288 QoQ
Shares Held
122,862
+64.1% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 184 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $706,217,774 across 100 Biotechnology names. SVRA ranks #76 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
251,711 | $112,399,029 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
874,089 | $65,635,343 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
836,981 | $52,478,708 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
479,476 | $44,293,992 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,164 | $24,851,192 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
134,792 | $22,782,543 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
1,019,951 | $22,194,133 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
384,681 | $20,280,382 |
All Filings in SVRA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $670,826 | 122,862 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $451,538 | 74,882 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $335,105 | 93,867 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $706,423 | 309,835 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,157,702 | 778,954 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,571,023 | 837,467 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,928,182 | 690,609 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,806,890 | 448,360 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,955,760 | 392,723 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,261,700 | 268,447 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $855,145 | 226,229 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $765,704 | 239,657 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $404,909 | 207,646 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $271,363 | 175,073 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $266,468 | 171,915 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $219,536 | 144,432 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $176,940 | 135,069 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $187,734 | 151,399 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $225,692 | 163,545 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $244,089 | 143,582 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $74,106 | 35,628 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||